Clinical Trial Update: Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing post-treatment effects of ivermectin and diethylcarbamazine in loiasis has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Loiasis

Drugs mentioned

• Diethylcarbamazine (diethylcarbamazine)
• IVERMECTIN (Ivermectin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Loiasis | Phase 4 | Status: COMPLETED | Results posted: 2016-11-09